Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引：1

作者：

Zhou, H. ^{[1
]}

Long, B. ^{[2
]}

Yu, Z. ^{[3
]}

Zhu, J. ^{[2
]}

Yang, H. ^{[4
]}

Zhang, W. ^{[3
]}

Guan, X. ^{[5
]}

Zhang, G. ^{[2
]}

Li, L. ^{[2
]}

Luo, C. ^{[2
]}

Cao, H. ^{[2
]}

Zhang, S. ^{[2
]}

Chen, S. ^{[2
]}

He, Q. ^{[2
]}

Gan, S. ^{[2
]}

Zhou, L. ^{[2
]}

Jiang, X. ^{[2
]}

Shi, W.

Huang, Z. ^{[5
]}

Mao, J. ^{[2
]}

Dong, C. ^{[6
]}

Jiao, Z. ^{[2
]}

机构：

[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China

[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China

[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China

[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China

[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China

[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-146

引用

页码：S66 / S67

页数：2

共 50 条

[11] Letter to the editor for the article 'Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study' [J].

Wang, Lexin ;

Wu, Qibiao ;

Chi, Hao ;

Yang, Guanhu .

INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (09) :6026-6027

[12] Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial [J].

Tang, Zhaoqing ;

Wang, Yan ;

Yu, Yiyi ;

Cui, Yuehong ;

Liang, Liang ;

Xu, Chen ;

Shen, Zhenbin ;

Shen, Kuntang ;

Wang, Xuefei ;

Liu, Tianshu ;

Sun, Yihong .

BMC MEDICINE, 2022, 20 (01)

[13] Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial [J].

Zhaoqing Tang ;

Yan Wang ;

Yiyi Yu ;

Yuehong Cui ;

Liang Liang ;

Chen Xu ;

Zhenbin Shen ;

Kuntang Shen ;

Xuefei Wang ;

Tianshu Liu ;

Yihong Sun .

BMC Medicine, 20

[14] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study [J].

Zhong, Wen-Jin ;

Lin, Jian-An ;

Wu, Chu-Ying ;

Wang, Jiantian ;

Chen, Jun-Xing ;

Zheng, Huida ;

Ye, Kai .

CANCER MEDICINE, 2024, 13 (03)

[15] Efficacy and safety of sintilimab plus XELOX as neoadjuvant therapy in patients with locally advanced gastric cancer: A single-arm open-label phase II trial. [J].

Guo, Honghai ;

Ding, Ping'an ;

Yang, Peigang ;

Tian, Yuan ;

Liu, Yang ;

Zhang, Ze ;

Zheng, Tao ;

Zhang, Zhidong ;

Wang, Dong ;

Tan, Bibo ;

Zhao, Xuefeng ;

Li, Yong ;

Zhao, Qun .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) :E16091-E16091

[16] Fruquintinib combined with sintilimab as a second-line therapy for advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC): A phase II, single-arm, prospective study. [J].

Jin, Min ;

Yang, Shengli ;

Liu, Junli ;

Zhang, Jieying ;

Zhao, Lei ;

Yu, Dandan ;

Lin, Zhenyu ;

Li, Pindong ;

Wang, Jing ;

Xue, Jun ;

Ma, Hong ;

Hu, Jianli ;

Zhang, Tao ;

Liu, Hongli .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :332-332

[17] Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial [J].

Le Zhang ;

Weixue Wang ;

Shaohua Ge ;

Hongli Li ;

Ming Bai ;

Jingjing Duan ;

Yuchong Yang ;

Tao Ning ;

Rui Liu ;

Xia Wang ;

Zhi Ji ;

Feixue Wang ;

Haiyang Zhang ;

Yi Ba ;

Ting Deng .

BMC Cancer, 23

[18] Sintilimab Plus Apatinib and Chemotherapy as Second-/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial [J].

Zhang, Le ;

Wang, Weixue ;

Ge, Shaohua ;

Li, Hongli ;

Bai, Ming ;

Duan, Jingjing ;

Yang, Yuchong ;

Ning, Tao ;

Liu, Rui ;

Wang, Xia ;

Ji, Zhi ;

Wang, Feixue ;

Zhang, Haiyang ;

Ba, Yi ;

Deng, Ting .

BMC CANCER, 2023, 23 (01)

[19] Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial [J].

Pan, Lanlan ;

Tian, Yitong ;

Wang, Kangxin ;

Tang, Jie ;

Liu, Jin ;

Zhang, Jiaguang ;

Wang, Min ;

Liu, Jie ;

Xu, Hao ;

Chen, Xiaofeng .

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, :3300-3313

[20] Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/ gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial [J].